MARKET

VRTX

VRTX

Vertex Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

201.90
+0.59
+0.29%
After Hours: 201.90 0 0.00% 16:42 11/11 EST
OPEN
200.98
PREV CLOSE
201.31
HIGH
202.21
LOW
199.29
VOLUME
825.16K
TURNOVER
--
52 WEEK HIGH
202.94
52 WEEK LOW
151.80
MARKET CAP
51.94B
P/E (TTM)
89.94
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VRTX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VRTX News

  • 2 Beaten-Down Biotech Stocks That Could Make You Rich
  • MotleyFool.com.9h ago
  • Celgene & Acceleron Get FDA Nod for Rare Blood Disorder Drug
  • Zacks.10h ago
  • CORRECTED-INSIGHT-US company directors compensated more than ever, but now risk backlash
  • Reuters.10h ago
  • Vertex: A Crown Jewel Of Biotech
  • Seeking Alpha - Article.15h ago

More

Industry

Biotechnology & Medical Research
-0.51%
Pharmaceuticals & Medical Research
-0.43%

Hot Stocks

Name
Price
%Change

About VRTX

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are ORKAMBI and KALYDECO. ORKAMBI (lumacaftor in combination with ivacaftor) is approved as a treatment for patients having two copies (homozygous) of the Delta-F508 (F508del) mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO (ivacaftor) is approved for the treatment of CF patients having the G551D mutation or other specified mutations in their CFTR gene. The Company's development programs in the field of CF include Tezacaftor (VX-661), VX-152, VX-440, VX-659, VX-445 and VX-371. VX-152, VX-440, VX-659 and VX-445 are CFTR corrector compounds.
More

Webull offers Vertex Pharmaceuticals Incorporated (VRTX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.